Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

MUCOSOLVAN 24 HOURS CAPSULE 75MG [SIN13373P]

Active ingredients: MUCOSOLVAN 24 HOURS CAPSULE 75MG

View product's general information
Last updated 24 April 2026

Product Info

MUCOSOLVAN 24 HOURS CAPSULE 75MG

[SIN13373P]

Product information

Active Ingredient and Strength

AMBROXOL HYDROCHLORIDE - 75 MG

Dosage Form

CAPSULE, DELAYED RELEASE

Manufacturer and Country

SANOFI WINTHROP INDUSTRIE - FRANCE

Registration Number

SIN13373P

Licence Holder

OPELLA HEALTHCARE SINGAPORE PTE. LTD.

Forensic Classification

GENERAL SALE LIST

Anatomical Therapeutic Chemical (ATC) code

R05CB06

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

(b) What MUCOSOLVAN once-daily prolonged-release capsules are and what they are used for

Mucosolvan is used in conditions where there are a lot of thick secretion or mucus in your air passages.

Mucosolvan contains ambroxol hydrochloride, which helps to clear the chest by thinning the mucus in your air passage.

Dosing

(d) How to take MUCOSOLVAN once-daily prolonged-release capsules

Always take this medicine exactly as described in this package leaflet or exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is: The usual dosage is one prolonged-release capsule (equivalent to 75 mg ambroxol hydrochloride/day) once daily.

Method and duration of treatment

MUCOSOLVAN once-daily prolonged-release capsules can be taken with or without food and should be swallowed whole with sufficient amounts of liquid (e.g., water, tea or fruit juice).

You should consult a doctor if your symptoms worsen or if there is no improvement after 4–5 days.

Please speak to your doctor or pharmacist if you feel that the effect of MUCOSOLVAN once-daily prolonged-release capsules is too strong or too weak.

If you take more MUCOSOLVAN once-daily prolonged-release capsules than you should

No specific symptoms of overdose have been reported to date. The symptoms observed in cases of accidental overdose or medication error are consistent with the side effects at the recommended dose (see Section (e) – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information). In the event of an overdose, please consult a doctor as symptomatic treatment may be required.

If you forget to take MUCOSOLVAN once-daily prolonged-release capsules

If you forget to take MUCOSOLVAN once-daily prolonged-release capsules or have taken an insufficient amount, please continue to take MUCOSOLVAN once daily prolonged-release capsules as described in the dosage instructions at the next scheduled time.

If you stop taking MUCOSOLVAN once-daily prolonged-release capsules

The symptoms may worsen if the treatment is discontinued prematurely.

Contraindications

(c) What you need to know before you take MUCOSOLVAN once-daily prolonged-release capsules

MUCOSOLVAN once-daily prolonged-release capsules should not be taken:

  • If you are hypersensitive (allergic) to the active substance ambroxol hydrochloride or to any of the other ingredients of this medicine listed in Section (a) – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.